Tesamorelin – 20mg Vial
$210.00 Original price was: $210.00.$145.00Current price is: $145.00.
GHRH analog for visceral adipose tissue & IGF-1 pathway research. FDA-studied compound for growth hormone investigations.
In Stock - Ships Out Today
Pricing Protocol BOgGO promo codes apply to standard MSRP. Active sale pricing will be adjusted upon code activation.
Why Choose This Product
Pharmaceutical-Grade Purity
Independently verified at ≥99% purity via LC-MS/MS testing
Lyophilized for Stability
Advanced freeze-drying preserves molecular integrity
Full Documentation Included
COA, endotoxin testing, and batch verification provided
Tesamorelin 20mg — GHRH Analogue Research Peptide
Tesamorelin 20mg is a synthetic growth hormone-releasing hormone (GHRH) analogue supplied by PeakForce Labs for laboratory research applications. Tesamorelin is a modified peptide based on the 44-amino-acid sequence of human GHRH and is investigated for its interaction with the growth hormone-releasing hormone receptor (GHRHR) and downstream endocrine-associated signaling pathways.
Each vial contains 20mg of lyophilized Tesamorelin supplied in a sealed glass vial and independently verified through rigorous third-party analytical testing.
Product Specifications
Compound: Tesamorelin
Research Classification: Synthetic GHRH analogue research peptide
Primary Research Target: Growth hormone-releasing hormone receptor (GHRHR)
Amino Acid Sequence: Trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂
Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight: Approximately 5135.77 g/mol
Form: Lyophilized powder
Vial Configuration: 20mg supplied in a sealed glass vial
Purity: ≥98% HPLC verified, with exact analytical results provided on the applicable batch-specific COA
Appearance: White to off-white powder
Testing: Independent third-party analytical verification protocol
Analytical Verification
Every applicable batch of Tesamorelin undergoes analytical testing designed to support peptide identity, purity, content, and consistency.
Identity Verification: Confirms that the research material corresponds to the specified Tesamorelin peptide.
Purity Quantification: HPLC analysis evaluates target peptide relative to applicable impurities and synthesis-related byproducts.
Net Peptide Content: Confirms the applicable quantity of peptide material within the vial.
Visual Appearance: Confirms physical consistency of the lyophilized material against established product specifications.
Mass Spectrometry / Molecular Weight: Evaluates molecular characteristics to support peptide identity and chemical composition.
Batch Documentation: Analytical results are documented through applicable batch-specific COAs.
Research Context
Tesamorelin is a synthetic analogue of human growth hormone-releasing hormone and is investigated primarily for its interaction with GHRH receptors and downstream endocrine-associated signaling.
The GHRH receptor is a G-protein-coupled receptor expressed prominently within pituitary-associated cellular systems. Activation of this receptor provides researchers with a framework for examining intracellular signaling mechanisms involved in the regulation of growth-hormone-associated pathways.
GHRH Receptor Research
Tesamorelin provides a defined research tool for investigating GHRH receptor pharmacology, ligand-receptor interactions, receptor activation, and downstream intracellular signaling.
GHRHR is primarily associated with Gs-protein-mediated signaling. Receptor activation is linked with adenylate cyclase activity, intracellular cyclic AMP (cAMP), protein kinase A-associated pathways, and downstream cellular responses.
These mechanisms make Tesamorelin relevant to experimental research involving class B G-protein-coupled receptor biology and endocrine-associated signaling.
Growth Hormone-Associated Signaling
GHRH receptor signaling participates in the physiological regulation of growth hormone synthesis and secretion.
Tesamorelin-associated experimental systems therefore provide a framework for examining relationships among GHRHR activation, intracellular second-messenger signaling, growth-hormone-associated pathways, and endocrine cellular biology.
This research context describes the peptide’s molecular pharmacology and does not establish growth promotion, physical enhancement, recovery, or other physiological outcomes.
GH / IGF-1 Axis Research
Growth hormone participates in signaling networks associated with insulin-like growth factor 1 (IGF-1).
Experimental investigation involving GHRH analogues can therefore be used to examine relationships among GHRH receptor activation, growth-hormone-associated signaling, IGF-1-associated pathways, and downstream cellular responses.
These pathways provide a research framework for studying endocrine signaling without establishing changes in circulating GH or IGF-1 concentrations in any particular experimental system.
Metabolic Signaling Research
The GH/IGF-1 signaling axis intersects with numerous metabolic pathways, making GHRH analogues relevant to experimental research involving cellular metabolism.
Laboratory models may examine relationships among GHRH receptor signaling, lipid-associated biochemical pathways, glucose-responsive cellular signaling, substrate metabolism, and endocrine-associated gene expression.
These areas of investigation do not establish visceral fat reduction, weight loss, improved glucose regulation, body-composition changes, or other metabolic outcomes.
Peptide Modification Research
Tesamorelin differs structurally from endogenous human GHRH through modification of the peptide sequence with a trans-3-hexenoyl group.
This structural characteristic provides researchers with an additional framework for examining relationships among peptide modification, molecular properties, receptor interaction, and peptide stability.
Tesamorelin 20mg is intended solely for in vitro research and laboratory investigation by qualified personnel in appropriate research environments.
Reconstitution and Storage
Lyophilized storage: Store sealed in a cool, dry location away from direct light
Long-term storage: -20°C for maximum stability where consistent with product-specific stability documentation
Post-reconstitution: Once reconstituted for research purposes, store reconstituted material at 2-8°C and protect from light
Reconstituted use window: Within 60 days for optimal research integrity where supported by product-specific stability documentation
Avoid: Repeated freeze-thaw cycles to preserve peptide stability and structural integrity
Quality Assurance
PeakForce Labs maintains rigorous quality-control standards across its research compounds. Our quality assurance procedures emphasize analytical verification, consistency, and traceability:
- Independent third-party analytical testing on applicable batches
- Peptide identity verification
- HPLC purity analysis
- Mass spectrometry verification where applicable
- Net peptide content verification
- Heavy metal screening where applicable
- Full product traceability
- Batch-specific COAs
- Same-day shipping available for orders placed before daily 3PM CST cutoff
Terms of Sale
By purchasing this product, the buyer confirms and attests that:
- They are 21 years of age or older
- They are a qualified research professional, authorized research personnel, or research institution
- They accept full responsibility for proper handling, storage, and use of this material in accordance with all applicable regulations
- They will not use this material for human consumption, veterinary use, or any in vivo application
About PeakForce Labs
PeakForce Labs is a Houston, Texas-founded research compound supplier specializing in high-quality research materials for laboratory applications. Our research products are supplied with an emphasis on analytical verification, product consistency, traceability, and quality assurance.
Trusted by the research community with top-tier Trustpilot reviews.
